Table of Contents
Chapter 1. Global Influenza Diagnostics Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer's Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Global Influenza Diagnostics Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Test Type
2.3.2. By End Use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Influenza Diagnostics Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Influenza Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Influenza Diagnostics Market Size & Forecasts by Test Type 2022-2032
5.1. RIDT
5.2. RT-PCR
5.3. Cell Culture
5.4. Others
Chapter 6. Global Influenza Diagnostics Market Size & Forecasts by End Use 2022-2032
6.1. Hospitals
6.2. POCT
6.3. Laboratories
Chapter 7. Global Influenza Diagnostics Market Size & Forecasts by Region 2022-2032
7.1. North America Influenza Diagnostics Market
7.1.1. U.S. Influenza Diagnostics Market
7.1.1.1. Test Type breakdown size & forecasts, 2022-2032
7.1.1.2. End Use breakdown size & forecasts, 2022-2032
7.1.2. Canada Influenza Diagnostics Market
7.2. Europe Influenza Diagnostics Market
7.2.1. U.K. Influenza Diagnostics Market
7.2.2. Germany Influenza Diagnostics Market
7.2.3. France Influenza Diagnostics Market
7.2.4. Spain Influenza Diagnostics Market
7.2.5. Italy Influenza Diagnostics Market
7.2.6. Rest of Europe Influenza Diagnostics Market
7.3. Asia-Pacific Influenza Diagnostics Market
7.3.1. China Influenza Diagnostics Market
7.3.2. India Influenza Diagnostics Market
7.3.3. Japan Influenza Diagnostics Market
7.3.4. Australia Influenza Diagnostics Market
7.3.5. South Korea Influenza Diagnostics Market
7.3.6. Rest of Asia Pacific Influenza Diagnostics Market
7.4. Latin America Influenza Diagnostics Market
7.4.1. Brazil Influenza Diagnostics Market
7.4.2. Mexico Influenza Diagnostics Market
7.4.3. Rest of Latin America Influenza Diagnostics Market
7.5. Middle East & Africa Influenza Diagnostics Market
7.5.1. Saudi Arabia Influenza Diagnostics Market
7.5.2. South Africa Influenza Diagnostics Market
7.5.3. Rest of Middle East & Africa Influenza Diagnostics Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. 3M Company
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Abbott Laboratories
8.3.3. Becton, Dickinson and Company (BD)
8.3.4. Meridian Bioscience, Inc.
8.3.5. Quidel Corporation
8.3.6. F. Hoffmann-La Roche Ltd
8.3.7. SA Scientific Ltd
8.3.8. SEKISUI Diagnostics
8.3.9. Thermo Fisher Scientific, Inc.
8.3.10. Hologic, Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes